BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25482684)

  • 1. Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controls.
    Pålsson E; Jakobsson J; Södersten K; Fujita Y; Sellgren C; Ekman CJ; Ågren H; Hashimoto K; Landén M
    Eur Neuropsychopharmacol; 2015 Jan; 25(1):133-40. PubMed ID: 25482684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in plasma D-serine, L-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment.
    Yamamori H; Hashimoto R; Fujita Y; Numata S; Yasuda Y; Fujimoto M; Ohi K; Umeda-Yano S; Ito A; Ohmori T; Hashimoto K; Takeda M
    Neurosci Lett; 2014 Oct; 582():93-8. PubMed ID: 25218715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low cerebrospinal fluid glutamate and glycine in refractory affective disorder.
    Frye MA; Tsai GE; Huggins T; Coyle JT; Post RM
    Biol Psychiatry; 2007 Jan; 61(2):162-6. PubMed ID: 16735030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bipolar mania and plasma amino acids: increased levels of glycine.
    Hoekstra R; Fekkes D; Loonen AJ; Pepplinkhuizen L; Tuinier S; Verhoeven WM
    Eur Neuropsychopharmacol; 2006 Jan; 16(1):71-7. PubMed ID: 16023835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum levels of serine enantiomers in patients with depression.
    Hashimoto K; Yoshida T; Ishikawa M; Fujita Y; Niitsu T; Nakazato M; Watanabe H; Sasaki T; Shiina A; Hashimoto T; Kanahara N; Hasegawa T; Enohara M; Kimura A; Iyo M
    Acta Neuropsychiatr; 2016 Jun; 28(3):173-8. PubMed ID: 26512905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between plasma levels of glutamate, alanine and serine with severity of depression.
    Mitani H; Shirayama Y; Yamada T; Maeda K; Ashby CR; Kawahara R
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1155-8. PubMed ID: 16707201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotransmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease.
    Jiménez-Jiménez FJ; Molina JA; Vargas C; Gómez P; Navarro JA; Benito-León J; Ortí-Pareja M; Gasalla T; Cisneros E; Arenas J
    J Neurol Sci; 1996 Sep; 141(1-2):39-44. PubMed ID: 8880690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormality in glutamine-glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study.
    Hashimoto K; Bruno D; Nierenberg J; Marmar CR; Zetterberg H; Blennow K; Pomara N
    Transl Psychiatry; 2016 Mar; 6(3):e744. PubMed ID: 26926880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia.
    Bendikov I; Nadri C; Amar S; Panizzutti R; De Miranda J; Wolosker H; Agam G
    Schizophr Res; 2007 Feb; 90(1-3):41-51. PubMed ID: 17156977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum levels of glutamate in adult patients with autism.
    Shinohe A; Hashimoto K; Nakamura K; Tsujii M; Iwata Y; Tsuchiya KJ; Sekine Y; Suda S; Suzuki K; Sugihara G; Matsuzaki H; Minabe Y; Sugiyama T; Kawai M; Iyo M; Takei N; Mori N
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1472-7. PubMed ID: 16863675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic alterations in medication-free patients with bipolar disorder: a 3T CSF-corrected magnetic resonance spectroscopic imaging study.
    Port JD; Unal SS; Mrazek DA; Marcus SM
    Psychiatry Res; 2008 Feb; 162(2):113-21. PubMed ID: 18164911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different serine and glycine metabolism in patients with schizophrenia receiving clozapine.
    Hons J; Vasatova M; Cermakova E; Doubek P; Libiger J
    J Psychiatr Res; 2012 Jun; 46(6):811-8. PubMed ID: 22502820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients.
    Hashimoto K; Engberg G; Shimizu E; Nordin C; Lindström LH; Iyo M
    BMC Psychiatry; 2005 Jan; 5():6. PubMed ID: 15683541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased glutamate/glutamine levels may mediate cytidine's efficacy in treating bipolar depression: a longitudinal proton magnetic resonance spectroscopy study.
    Yoon SJ; Lyoo IK; Haws C; Kim TS; Cohen BM; Renshaw PF
    Neuropsychopharmacology; 2009 Jun; 34(7):1810-8. PubMed ID: 19194376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of d-serine and related neuroactive amino acids in human plasma by high-performance liquid chromatography with fluorimetric detection.
    Grant SL; Shulman Y; Tibbo P; Hampson DR; Baker GB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Dec; 844(2):278-82. PubMed ID: 16890503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of plasma and cerebrospinal fluid glutamate levels in rats treated with the N-methyl-D-aspartate receptor antagonist, ketamine.
    Tomiya M; Fukushima T; Kawai J; Aoyama C; Mitsuhashi S; Santa T; Imai K; Toyo'oka T
    Biomed Chromatogr; 2006; 20(6-7):628-33. PubMed ID: 16779778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum amino acids as indicators of cerebrospinal neuronal activity in patients with micturition disorders.
    Nishijima S; Sugaya K; Fukuda T; Miyazato M; Ashimine S; Ogawa Y
    Int J Urol; 2006 Dec; 13(12):1479-83. PubMed ID: 17118021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotransmitters in cerebrospinal fluid reflect pathological activity.
    Stover JF; Pleines UE; Morganti-Kossmann MC; Kossmann T; Lowitzsch K; Kempski OS
    Eur J Clin Invest; 1997 Dec; 27(12):1038-43. PubMed ID: 9466133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms.
    Sumiyoshi T; Anil AE; Jin D; Jayathilake K; Lee M; Meltzer HY
    Int J Neuropsychopharmacol; 2004 Mar; 7(1):1-8. PubMed ID: 14720317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia.
    Hashimoto K; Fukushima T; Shimizu E; Komatsu N; Watanabe H; Shinoda N; Nakazato M; Kumakiri C; Okada S; Hasegawa H; Imai K; Iyo M
    Arch Gen Psychiatry; 2003 Jun; 60(6):572-6. PubMed ID: 12796220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.